June 2016 - Antwerp, Belgium
Meeting objectives:
- To review cultural, infrastructural and financial barriers that impact implementation of vaccination and screening programmes.
- To review the adverse events profile following HPV vaccination.
- To update the points of view regarding safety issues and describe new developments.
- To discuss the impact of safety issues and crises in an international perspective.
- To review factors impacting adherence to cervical screening programmes.
- To learn from country initiatives in HPV vaccine safety monitoring and HPV screening adherence.
- To propose strategies to counter vaccination and screening hesitancy and to build public confidence in the HPV prevention programs
- To discuss a new approach to implement HPV prevention and control: HPV-Faster.
(pdf, 2.34 MB)
June 27, 2016
SESSION 1: OPENING
Chairs: Lauri Markowitz & Pierre Van Damme
- (pdf, 675 KB)
Alex Vorsters, University of Antwerp
SESSION 2: INTERPRETATION OF SAFETY DATA
Chairs: Lauri Markowitz & Pierre Van Damme
- (pdf, 2.01 MB)
Robert Pless, Public Health Agency of Canada GACVS
- (pdf, 1.25 MB)
Pier Luigi Lopalco, University of Pisa (Italy)
- (pdf, 931 KB)
Hannah Nohynek, National Institute for Health and Welfare (Finland)
- Vaccine safety - Mortality after HPV vaccination observed in RCTs
Marc Arbyn, Scientific Institute of Public Health (Belgium)
- Questions & Discussion​
SESSION 3: VACCINE CONFIDENCE
Chairs: Pier Luigi Lopalco & Monica Chaturvedi
- (pdf, 3.58 MB)
Heidi Larson and Emilie Karafillakis, London School of Hygiene and Tropical Medicine (UK)
- Questions and Discussion
- (pdf, 3.07 MB)
Heidi Larson and Emilie Karafillakis
- Questions & Discussion​
SESSION 4: HPV VACCINATION PROGRAMS: COUNTRY EXPERIENCES AND LESSONS LEARNT
Chairs: Margaret Stanley & Joakim Dillner
- (pdf, 1.49 MB)
Kevin Pollock, Health Protection Scotland
- (pdf, 1.88 MB)
Monica Chaturvedi, Public Health Foundation (India)
- The Japanese HPV vaccine tragedy and the take-home message
Sharon Hanley, Hokkaido University Graduate School of Medicine (Japan)
- (pdf, 2.36 MB)
Joanne Yarwood, National Infection Service, Public Health England (UK)
- (pdf, 1.61 MB)
Lauri Markowitz, Centre for Disease Control & Prevention (CDC) (US)
- (pdf, 1.46 MB)
Geert Top, Flemish Agency for Care and Health (Belgium))
- Questions & Discussion​
SESSION 4: HPV VACCINATION PROGRAMS: COUNTRY EXPERIENCES AND LESSONS LEARNT (³¦´Ç²Ô³Ù’d)
Chairs: Mira Kojouharova & Paolo Bonanni
- (pdf, 1.16 MB)
Patriciu Achimas, The Oncology Institute "Prof. Dr. Ion Chiricuta" (Romania)
- (pdf, 2.99 MB)
Kate Gallagher (presenting on behalf of Deborah Watson-Jones), London school of Hygiene and Tropical Medicine (UK)
- (pdf, 1.40 MB)
Xavier Bosch, Catalanian Institute of Ocology (Spain)
- Questions & Discussion
June 28, 2016
SESSION 4: HPV VACCINATION PROGRAMS: COUNTRY EXPERIENCES AND LESSONS LEARNT (³¦´Ç²Ô³Ù’d)
Chairs: Liudmila Mosina & Mario Poljak
- (pdf, 1.93 MB)
Kåre Mølbak, Statens Serum Institute, Division of Epidemiology and Disease Surveillance (Denmark)
SESSION 5: BARRIERS AND OPPORTUNITIES IN HPV SCREENING PROGRAMS
- (pdf, 1.54 MB)
Laura Marlow, Department of Epidemiology and Public Health, UCL (UK)
- (pdf, 1.53 MB)
Scott Wittet, PATH (US)
- (pdf, 2.24 MB)
Pamela Wakewich, Lakehead University (Canada)
- (pdf, 424 KB)
Patriciu Achimas, The Oncology Institute "Prof. Dr. Ion Chiricuta" (Romania)
- Questions & Discussion​
SESSION 6: HPV-FASTER: BROADENING THE SCOPE FOR PREVENTION OF HPV-RELATED CANCER
Chairs: Susan Wang & Marc Arbyn
- (pdf, 1.75 MB)
Xavier Bosch Catalanian Institute of Ocology (Spain)
- (pdf, 945 KB)
Silvia de Sanjose, Catalanian Institute of Ocology (Spain)
- (pdf, 1.66 MB)
Iacopo Baussano, International Agency (France)
SESSION 7: CONCLUSION OF THE MEETING
Chairs: Mark Kane & Xavier Bosch
- (pdf, 532 KB)
Marc Baay